Epidemiological studies show that oestrogen reduces the risk of colorectal cancer in postmenopausal women and ERβ (oestrogen receptor β)-selective ligands have been reported to be very effective treatment in animal models of inflammatory bowel disease. Several studies have shown that ERβ is the predominant ER in the colonic epithelium, but it is not clear whether the benefit of ERβ agonists in inflammatory bowel disease are due to their action on the colon epithelium itself, or on the immune system. In order to address this issue, we have compared colons of ERβ−/− and wild-type mice with regard to morphology, histology, proliferation and differentiation. We found that the number of proliferating cells was higher in ERβ−/− mice, and the migration of labelled cells from base to lumen of the crypts was faster. Additionally, immunohistochemical staining revealed fewer apoptotic cells (cleaved caspase 3-positive), a significant decrease in expression of the epithelial differentiation marker, cytokeratin CK20, the adherens junction protein, α-catenin, and the hemidesmosomal protein, plectin, in ERβ−/− mice. These findings suggest a role for ERβ in growth, organization and maintenance of the normal colonic crypt–villus architecture. The next step is to elucidate the molecular mechanisms that underlie the signalling of ERβ in normal cell growth and assess whether or not ERβ agonists will be useful drugs in the prevention or treatment of colorectal cancer. Dietary phyto-oestrogens are believed to play a role in protection against colorectal cancer. Lignans, such as enterolactone, an ER agonist, prevent cancer development in animal models. Since ERβ is the only ER in the colon, there is enough reason to speculate that phyto-oestrogens are acting through ERβ.
Skip Nav Destination
Article navigation
December 2006
-
Cover Image
Cover Image
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
Conference Article|
October 25 2006
New developments in oestrogen signalling in colonic epithelium
O. Wada-Hiraike;
O. Wada-Hiraike
1Department of Biosciences and Nutrition, Karolinska Institutet, Novum, SE-141 86 Stockholm, Sweden
Search for other works by this author on:
M. Warner;
M. Warner
1Department of Biosciences and Nutrition, Karolinska Institutet, Novum, SE-141 86 Stockholm, Sweden
Search for other works by this author on:
J.-Å. Gustafsson
J.-Å. Gustafsson
1
1Department of Biosciences and Nutrition, Karolinska Institutet, Novum, SE-141 86 Stockholm, Sweden
1To whom correspondence should be addressed (email jan-ake.gustafsson@mednut.ki.se).
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
June 15 2006
Online ISSN: 1470-8752
Print ISSN: 0300-5127
© 2006 The Biochemical Society
2006
Biochem Soc Trans (2006) 34 (6): 1114–1116.
Article history
Received:
June 15 2006
Citation
O. Wada-Hiraike, M. Warner, J.-Å. Gustafsson; New developments in oestrogen signalling in colonic epithelium. Biochem Soc Trans 1 December 2006; 34 (6): 1114–1116. doi: https://doi.org/10.1042/BST0341114
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Captcha Validation Error. Please try again.